ClinicalTrials.Veeva

Menu

Novel Risk Factors of Atrial Fibrillation in Patients With Chronic Heart Failure

Y

Yangzhou No.1 People's Hospital

Status

Unknown

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT02655185
2016003

Details and patient eligibility

About

The purpose of this study is to determine whether lipid levels are related with incidence of atrial fibrillation in Patients with chronic heart failure.

Full description

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice. Chronic Heart failure (CHF) has become a major clinical and public health problem. Both AF and CHF often co-exist and complicate each other's administration.Several risk factors have been demonstrated to be associated with the risk of AF in Patients with CHF.

Lopez et al. found that higher levels of low-density lipoprotein cholesterol (LDLc) and total cholesterol were associated with a lower incidence of AF independently of other risk factors from the Atherosclerosis Risk in Communities (ARIC) study.

Thus the purpose of this study is to determine whether lipid levels are related with incidence of atrial fibrillation in Patients with chronic heart failure. This study maybe provide a novel opinion on the prevention of AF in patients with CHF.

Enrollment

300 estimated patients

Sex

All

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of chronic heart failure

Exclusion criteria

  • Use of statins

Trial design

300 participants in 1 patient group

Heart failure

Trial contacts and locations

0

Loading...

Central trial contact

Chen - Liu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems